Grace Therapeutics, Inc. (GRCE)
US$ 2.95-4.53%
Price Chart
Key Statistics
Market Cap
$ 34.98M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
6.03K
52W High
$ 4.97
52W Low
$ 1.75
Dividend Yield
0.00%
Beta
1.37
Technicals
50-Day MA
3.7296
200-Day MA
3.1105
52 Week High
4.97
52 Week Low
1.75
About GRCE
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
Employees
N/A
Headquarters
Princeton, NJ
CEO
Mr. Prashant Kohli
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg